Multiple splenic calcificationsFYFE, Andrew J; GALLIPOLI, Paolo.British journal of haematology. 2009, Vol 144, Num 6, pp 808-808, issn 0007-1048, 1 p.Article

The evolving management of a rare lymphoproliferative disorder―T-cell prolymphocytic leukemiaGALLIPOLI, Paolo; CLARK, Andrew; LEACH, Mike et al.American journal of hematology. 2009, Vol 84, Num 11, pp 750-753, issn 0361-8609, 4 p.Article

Neutrophil-specific granule deficiencyMCILWAINE, Louisa; PARKER, Anne; SANDILANDS, Gavin et al.British journal of haematology. 2013, Vol 160, Num 6, issn 0007-1048, p. 735Article

Restricted access to second generation tyrosine kinase inhibitors in the UK could result in suboptimal treatment for almost half of chronic myeloid leukaemia patients: results from a West of Scotland and Lothian population studyGALLIPOLI, Paolo; SHEPHERD, Pat; IRVINE, David et al.British journal of haematology. 2011, Vol 155, Num 1, pp 128-130, issn 0007-1048, 3 p.Article

Targeted therapy in haematological malignanciesHAMILTON, Ashley; GALLIPOLI, Paolo; NICHOLSON, Emma et al.Journal of pathology (Print). 2010, Vol 220, Num 4, pp 404-418, issn 0022-3417, 15 p.Article

Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1―BCR-ABL―JAK2 ComplexMIN CHEN; GALLIPOLI, Paolo; LAMBIE, Karen et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 6, pp 405-423, issn 0027-8874, 19 p.Article

Hurdles Toward a Cure for CML: The CM L Stem CellGALLIPOLI, Paolo; ABRAHAM, Sheela A; HOLYOAKE, Tessa L et al.Hematology/oncology clinics of North America. 2011, Vol 25, Num 5, issn 0889-8588, 951-966, v [17 p.]Article